Latest news
Debiopharm Ignites Oncology Innovation with Clinical and Translational Data on Debio 0123 at the 2025 ASCO Annual Meeting in Chicago
Carb-X Grants Debiopharm An Additional $12.3 Million To Advance Development Of Novel Antibiotic Against Gonorrhea
Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research
Debiopharm to Reveal Insights from their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at The 2025 AACR Conference in…
Debiopharm mutualise son infrastructure de bornes de recharges pour les taxis électriques ou hybrides de Lausanne
MEDSIR & Debiopharm Announce the First Patient Dosed in the WIN-B Trial Exploring the Combination of Debio 0123 & Gilead’s…
Genialis advances biomarker discovery to reduce risk in cancer drug development targeting DNA damage response pathways